![](https://investorshub.advfn.com/uicon/130490.png?cb=1502700362)
Sunday, January 27, 2013 1:45:23 PM
Arrayit Corporation (OTCQB: ARYC) met with Amarantus Bioscience (OTCQB: AMBS), a leading company focused on the discovery and development of secreted proteins including MANF and small molecule therapeutics for the treatment Parkinson’s Disase and other neurological disorders. Shown in the photograph (left to right) are Dr. Paul Cannon from Tynan Consulting LLC, Dr. Essam Sheta from Oncology Consultants, Arrayit Corporation Chairman and CEO Rene Schena, Arrayit Corporation President and CSO Dr. Mark Schena, Amarantus Bioscience President and CEO Gerald Commissiong, Dr. Katherine Tynan from Tynan Consulting LLC, and Amarantus Bioscience CSO Dr. John Commissiong. Photo taken at Arrayit headquarters in Sunnyvale, CA on January 6, 2013.
FDA Approval
Arrayit PDx™ Pre-Symptomatic Test for Parkinson’s Disease will be submitted to the United Sates Food and Drug Administration (FDA) as a 510(k) submission in the near future.
![](http://arrayit.com/Microarray_Diagnostics/Parkinsons_Disease/Arrayit-Corporation-Amarantus-Bioscience.jpg)
Please do not take my post as a buy or sell recommendation, please do your own DD.
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM